Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001815974-20-000002
Filing Date
2020-06-25
Accepted
2020-06-25 15:30:41
Documents
1
Effectiveness Date
2020-06-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5699
  Complete submission text file 0001815974-20-000002.txt   6751
Mailing Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

IRS No.: 851170950 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-369711 | Film No.: 20989128